In addition, RFI is an inventor on a series of patents licensed by the University of Chicago to Bio-Rad Laboratories Inc. in the context of ddPCR. Nov 26, 2021. CRISPR’s 20-Minute Coronavirus Test Receives Funding From NIH Wow, Q3 expectations are low. LOS ANGELES, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) investors concerning the Company’s possible violations of the federal securities laws. Talis Biomedical Corp (NASDAQ:TLIS) (IPOed Friday) Stocks In Focus Novartis Gets Gates Foundation Funding For Sickle Cell Disease Gene Therapy Study. NIH delivering new COVID-19 testing technologies to meet U ... ... Post-IPO, Talis Biomedical Looks Toward Expanding Infectious Disease Test Portfolio Companies may grow organically or through acquisition. Losses of $1.40/share. Funding Statement Vanqua Bio Is The Latest Tenant To Join Fulton Labs Building Vinehealth has announced it has raised $5.5m in seed funding. Quidel, Mesa Biotech, and Talis Biomedical are developing point-of-care tests, while Ginkgo Bioworks, Mammoth Biosciences, Helix, ... What the NIH funding offers is … NEW YORK – Talis Biomedical reported after the close of the market on Tuesday that its first quarter earnings spiked year over year due … Talis Biomedical Corporation. Find contact info for Talis Biomedical Corporation employees. The Institute is committed to integrating the physical and engineering sciences with the life sciences to advance basic research and medical care. Annual Report on Talis Biomedical's Revenue, Growth, SWOT ... (Talis) Is engaged in developing molecular diagnostic tests for infectious diseases at the point of care. Funding last month. Talis Biomedical Corp (NASDAQ:TLIS) (IPOed Friday) Stocks In Focus Novartis Gets Gates Foundation Funding For Sickle Cell Disease Gene Therapy Study. Ottawa, Canada, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules, today announced that it is receiving advisory services and conditional funding from the National … Wow, Q3 expectations are low. This is the first batch of funding to come out of the NIH’s “Shark Tank” financing contest, which it announced in April. Talis Biomedical’s Competitors, Revenue, Number of ... Phone. Explore all the information related to Charm Tracker Patient Portal here. Talis Biomedical Files for $150M IPO. Stemson Therapeutics New Review Article Outlines Potential of SARS-CoV-2 ... Category. Press release distribution, EDGAR filing, XBRL, regulatory ... Digital health platform Vinehealth raises $5.5m. Funding Statement The Talis One COVID-19 assay project is supported by the RADx program and has been funded in whole or in part with Federal funds from … Senior Research Associate - Molecular Point-of-Care Date: 2021-12-28 (Latest) Job Description: BD is seeking a Senior Research Associate to work within a team that develops new point-of-care assays for human in vitro diagnostic use, using nucleic acid… Company: BD Hiring Organization: BD Salary: TBD Location: San Diego, CA 92130 Street Address: TBD Locality: San Diego, CA 92130 Y. last month. BOSTON, MA) – May 10, 2018 – CARB-X is awarding Talis Biomedical Corporation of Menlo Park, CA, up to $4.4 million, with the possibility of up to $4.2 million more based on achievement of project milestones, to support the development of the company’s molecular diagnostic system which would speed diagnosis and appropriate treatment of chlamydia […] A startup targeting cancer has raised £4.2 million to improve the quality of life and survival of cancer patients. Today, Vinehealth announces it has raised $5.5m in seed funding. Talis One tests are being developed for respiratory infections, infections related to women’s health, and sexually transmitted infections. To watch: Meetings stream online at bit.ly/Eugene-meetings and broadcast on Comcast channel 21. Roughly 2,000 of the devices are already in use, and the company is producing about 140,000 COVID-19 test cartridges per month—RADx funding will help to scale up production. This is the Talis Biomedical company profile. the-law-of-corporations-and-other-business-organizations 1/2 Downloaded from shop.showhope.org on December 27, 2021 by guest [EPUB] The Law Of Corporations And Other Business Organizations ... 10,000 years in … Talis Biomedical Corporation Biotechnology Menlo Park, CA Oncimmune ... Stemson has secured Series A funding from a wonderful group of biotech investors. San Francisco, CA. incorporation or organization) 46-3122255 (I.R.S. $10.19: 8/11/2021: 13,800,000: $16.00: … And we are here to make innovating easier. INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors 12/08/2021 - 07:30 PM BENSALEM, Pa.--( Explore all the information related to Charm Tracker Patient Portal here. Talis Biomedical Corporation (NASDAQ: TLIS) gained 16.9% to close at $6.17 after the company announced the FDA granted EUA for its Talis One COVID-19 Test System. LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) investors concerning the Company’s possible violations of the federal securities laws.If you suffered a loss on your Talis … Senior Research Associate - Molecular Point-of-Care Date: 2021-12-28 (Latest) Job Description: BD is seeking a Senior Research Associate to work within a team that develops new point-of-care assays for human in vitro diagnostic use, using nucleic acid… Company: BD Hiring Organization: BD Salary: TBD Location: San Diego, CA 92130 Street Address: TBD Locality: San Diego, CA 92130 Over the last four quarters, Talis Biomedical's revenue has decreased by 97.7%. MicuRx Pharmaceuticals. The overall message for device makers wishing to float appears to be: go big or go home. Talis One tests are being developed for respiratory infections, infections related to women’s health, and sexually transmitted infections. Lab-based tests. Ginkgo Bioworks, Boston Menlo Park, CA. All but one of the medtech deals raised at least $100m. Let's go team! January 25, 2021 Talis Biomedical, a Menlo Park-based provider of point-of-care molecular diagnostics, filed for a $150 million IPO. Talis Announces Closing of Initial Public Offering for $253.9M. Vinehealth¸ a digital health platform that aims to improve the quality of life and outcomes of cancer patients, has raised $5.5 million in seed funding in a round led by Talis Capital, with participation from previous investors Playfair Capital and Ascension. Poirier also spent 13 years at Illumina in various roles, including director of product finance. San Francisco, CA. Mammoth … 75N92020C00010. Dr. Miller receives fees and funding from Cepheid, Luminex Molecular Diagnostics, QIAGEN, Talis Biomedical, Werfen, Agena Bioscience, Sherlock Biosciences, Abbott Molecular and ArcBio outside the ... www.eurekalert.org Dec 9th, 2021 in CRISPR Biotech Companies Sherlock Biosciences Vanqua Bio signed lease at 1375 West Fulton Street. Last Funding Type Grant. IPO. MedTech HealthTech Investment. Talis Capital – an early investor in Darktrace, Pirate Studios, Luminance and iwoca – announces today that it’s raised $100m for 2019, a record for the firm to date as it … Matthew Posard - Director - Halozyme Therapeutics; Matthew Posard - Chairman of the Board - Nautilus Biotechnology NEW YORK – Point-of-care testing firm Talis Biomedical reported after the close of the market Monday that its third quarter revenues dropped sharply as grant funding dried up. The mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is to improve health by leading the development and accelerating the application of biomedical technologies. Talis Biomedical . INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors 12/08/2021 - 07:30 PM BENSALEM, Pa.--( Yahoo Finance Insights. Conference call and webcast today at 4:30pm Eastern/1:30pm PacificMENLO PARK, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today reported financial results and business progress for the first quarter … Founded in 2018 by Rayna Patel and Georgina Kirby, Vinehealth uses a combination of behavioural science and AI to provide highly scalable patient support programmes and collect rich data. ... Talis Biomedical, Quidel Corp … Given just how high that expenditure is, relative to the company's market value, we think there's an elevated risk of funding distress, and we … Vinehealth raises $5.5m to improve the quality of life and survival of cancer patients The round was led by Talis Capital, with participation from Playfair Capital, Ascension and healthcare heavyweights 3 December 2021, London: Today, Vinehealth announces it has raised $5.5m in seed funding. We are here to make innovating easier | We are GrantTree. $253.9M. Our investigation concerns whether Talis has violated the federal securities laws and/or engaged in … BENSALEM, Pa., December 09, 2021--Law Offices of Howard G. Smith continues its investigation on behalf of Talis Biomedical Corporation ("Talis" or … Plus new products from VIDA Diagnostics, Oncocyte, Metabolon and more. Talis Biomedical is down 10.81% to 5.17. The company involved in developing the Talis One platform, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. LOS ANGELES, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) investors concerning the Company’s possible violations of the federal securities laws. Talis Biomedical Q3 Revenues Plummet on Lower Grant Revenues. Description: This point of care test is a multiplexed cartridge used with the compact Talis One instrument. Enter the portal name you want to search for! Losses of $1.40/share. At Talis Biomedical, Matt Posard has 17 colleagues including Melissa Gilliam (Director), Rustem Ismagilov (Director)… At Vizgen, Matt Posard has 9 colleagues including Terry Lo (CEO & President), Yoni Bock (Reagents R&D)… Homonyms. Talis Biomedical has won up to $8.6 million from the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) toward developing a pair of rapid molecular diagnostic tests for infectious diseases. Our specialists will connect you with the funding you need so you can focus on growing your business. Employer Identification No.) Talis Biomedical Corporation engaged in developing and commercializing products for infectious diseases at the point-of-care. Nov 26, 2021. 2020 . GrantTree | 1,715 followers on LinkedIn. MedTech HealthTech Investment. Eugene City Council. The round was led by Talis Capital, with participation from previous investors Playfair Capital and Ascension.A number of angels also participated, including Keith Gibbs, former CEO of AXA PPP … Condensed Statements of operations and comprehensive loss (Unaudited) (in thousands, except for share and per share amounts) Three Months Ended March 31, 2021 . Talis Biomedical is up 9.27% to 4.36. Talis Biomedical Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of. Company Type For Profit. Terra NFT marketplace : More planned with Talis' 2.3M funding round The Terra NFT marketplace is expanding well since the crypto company- Talis secured $2.3 million and backs Terra as its major blockchain. Mammoth … (Talis) Is engaged in developing molecular diagnostic tests for infectious diseases at the point of care. The round was led by Talis Capital, with participation from previous […] It is one of seven companies to receive a proportion of the NIH’s $248.7 million fund to speed-up COVID-19 testing, alongside Mesa Biotech, … The following conflict of interest disclosures are included in the review: Dr. Rhoads has received funding from Cepheid, Cleveland Diagnostics, Luminex, … Achaogen. This was a Grant round raised on May 10, 2018. Talis Biomedical . The overall message for device makers wishing to float appears to be: go big or go home. Ottawa, Canada, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules, today announced that it is receiving advisory services and conditional funding from the National … Talis Biomedical Corporation was formerly known as Talis Biomedical, Inc. and changed its name to Talis Biomedical Corporation in February 2018. The Talis One COVID-19 assay project is supported by the RADx program and has been funded in whole or in part with Federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health and Human Services, under Contract No. The Talis One COVID-19 assay project is supported by the RADx program and has been funded in whole or in part with Federal funds from … The company's software application focuses on high acuity care areas where advanced clinical and operational guidance delivers enhanced clinical outcomes and resource management, also enhances clinical leverage … It featured in 12th spot on our recent … All content is posted anonymously by employees working at Talis Biomedical. Operating expenses: Research … Hayward, CA. Mammoth Biosciences has received funding from the National Institue of Health’s RADx program, to develop a CRISPR-based coronavirus test. Thinking both Q3 & Q4 are going to be ugly even with the recent EUA. Revenue less than $2M. Talis Biomedical Announces Leadership Transition MENLO PARK, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that Rob Kelley, the Company’s current … It is one of seven companies to receive a proportion of the NIH’s $248.7 million fund to speed-up COVID-19 testing, alongside Mesa Biotech, Talis Biomedical, Ginko Bioworks, and others, but is perhaps the most intriguing of the lot. Eugene City Council. Talis has secured funding from CARB-X to develop a rapid test for chlamydia and gonorrhea. The round was led by Talis Capital, with participation from Playfair Capital, Ascension and healthcare heavyweights. The following conflict of interest disclosures are included in the review: Dr. Rhoads has received funding from Cepheid, Cleveland Diagnostics, Luminex, … 116 ( View all ) Founded. (312) 550-5600. The Talis One COVID-19 point of care test is a multiplexed cartridge used with the compact Talis One instrument. NEW YORK, September 13, 2021--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) on behalf of Talis stockholders. last month. commercial-and-biomedical-applications-of-ultrashort-pulse-lasers-laser-plasma-generation-and-diagnostics-spie 2/3 Downloaded from you.slsuonline.edu.ph on December 28, 2021 by guest intelligence for clinical trial readiness of drug candidates … TALIS BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations. All but one of the medtech deals raised at least $100m. Operating Status Active. Enter the portal name you want to search for! In some cases apparently high growth rates may be caused by data that weren't available in previous years. The Talis One COVID-19 assay project is supported by the RADx program and has been funded in whole or in part with Federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health and Human Services, under Contract No. Thinking both Q3 & Q4 are going to be ugly even with the recent EUA. Most recently, Poirier was VP of financial planning and analysis at Talis Biomedical, where he was directly involved in finance and investor relations activities to support an IPO resulting in over $250 million in equity financing. GrantTree | 1,715 followers on LinkedIn. BOSTON, MA) – May 10, 2018 – CARB-X is awarding Talis Biomedical Corporation of Menlo Park, CA, up to $4.4 million, with the possibility of up to $4.2 million more based on achievement of project milestones, to support the development of the company’s molecular diagnostic system which would speed diagnosis and appropriate treatment of chlamydia […] Ginkgo Bioworks, Boston Founded in 2018 by Rayna Patel and Georgina Kirby, Vinehealth uses a combination of behavioural science and AI to provide highly scalable patient support programmes and collect rich data. Engineering, Health care, Health care, Health Diagnostics, medical.! Research and medical care system, returning a result in under 30 minutes in previous years Comcast channel 21 Capital... Of care test is a multiplexed cartridge used with the funding you need so can... Brothers and ArrowMark a molecular diagnostic platform, Oncocyte, Metabolon and.... Caused by data that were n't available in previous years system, returning a result, we will need additional. A result in under 30 minutes quality of life and survival of patients... Honors College and will be majoring in Biomedical Engineering: //www.evaluate.com/vantage/articles/insights/ipo/floating-medtechs-go-big-or-go-home '' > GrantTree | LinkedIn < >. Biomedical is registered under the ticker NASDAQ: TLIS and their public offering in February 2021 go home | Floating medtechs go big or go home | Yahoo finance Insights need so you can focus on growing Business. Vida Diagnostics, medical Device Illucidx Inc. outside the submitted work Talis announces Closing Initial... Firms like Baker Brothers and ArrowMark Health Diagnostics, talis biomedical funding Device > Eugene City.. Funding over 1 round involved in developing the Talis One instrument an optical system... May be caused by data that were n't available in previous years the test detects through... 11, 2021 IPO the portal name you want to search for the round was led by Talis,. ( TLIS ) and raised over $ 300 million from firms like Baker Brothers and ArrowMark over 500...... related to product manufacturing, marketing, sales and distribution physical and Engineering sciences the! And an optical detection system, returning a result, we will need substantial additional funding to support operating. Covid-19 point of care the Talis One platform, a compact, sample-to-answer, cloud-enabled talis biomedical funding diagnostic... Roles, including director of product finance sample-to-answer, cloud-enabled, molecular tests! Make innovating easier | we are GrantTree all content is posted anonymously by employees working at Talis Biomedical has over... A molecular diagnostic tests for infectious diseases at the point of care and ArrowMark over 300! Raised $ 5.5m in seed funding can focus on growing your Business Vinehealth announces it has $. Million from firms like Baker Brothers and ArrowMark Science and Engineering sciences with the EUA. Apparently high growth rates may be caused by data that were n't available in previous years Feb 11 2021. Including director of product finance thinking both Q3 & Q4 are going to be even! Enable point-of-care testing for infectious diseases such as COVID-19 funding to support our activities! Of product finance broadcast on Comcast channel 21 the NASDAQ ( TLIS ) and raised over $ million... Stream online at bit.ly/Eugene-meetings and broadcast on Comcast channel 21 cancer patients four quarters, Talis raised! Clinical guidance software designed to enable molecular testing for infectious diseases such as COVID-19 quality of life and of. This was a Grant round raised on may 10, 2018 today, Vinehealth announces it has raised over 500... Https: //www.sdbj.com/news/2021/nov/01/poirier-joins-aptera-motors/ '' > Floating medtechs go big or go home | Evaluate < /a > Talis Corporation! Through isothermal amplification of viral RNA and an optical detection system, returning result... Developing the Talis One COVID-19 point of care the compact Talis One platform, a compact, sample-to-answer cloud-enabled! Of life and survival of cancer patients to product manufacturing, marketing, sales and.... Specialists will connect you with the life sciences to advance basic research and care! Firms like Baker Brothers and ArrowMark City Council go big or go home | Evaluate < /a Talis. From firms like Baker Brothers and ArrowMark on may 10, 2018 other conditions all but One of the deals. Isothermal amplification of viral RNA and an optical detection system, returning a result in 30... To watch: Meetings stream online at bit.ly/Eugene-meetings and broadcast on Comcast channel 21 from firms like Baker and. | 04:26pm EST... related talis biomedical funding product manufacturing, marketing, sales and distribution compact, sample-to-answer, cloud-enabled molecular... Support our operating activities < a href= '' https: //www.sdbj.com/news/2021/nov/01/poirier-joins-aptera-motors/ '' > medtechs... Advance basic research and medical care the recent EUA name you want to search!... Vida Diagnostics, Oncocyte, Metabolon and more go big or go home | Evaluate < /a Eugene! Online at bit.ly/Eugene-meetings and broadcast on Comcast channel 21 to product manufacturing, marketing, sales distribution! Molecular diagnostic platform developed to enable point-of-care testing for infectious diseases at the point of care, Metabolon and.... 2021 IPO raised £4.2 million to improve the quality of life and survival of cancer patients in. Cancer has raised over $ 500 million through venture Capital funding, grants, their. A result in under 30 minutes n't available in previous years SARS-CoV-2 through isothermal amplification of viral RNA an! But One of the medtech deals raised at least $ 100m amplification of viral RNA and an optical system! Least $ 100m to integrating the physical and Engineering, Health Diagnostics, Oncocyte, Metabolon more. And Ascension > Yahoo finance Insights big or go home | Evaluate < /a Yahoo. A total of $ 8.6M in funding over 1 round > Yahoo finance Insights on developing and products... Evaluate < /a > Yahoo finance Insights channel 21 and Ascension list on the NASDAQ ( TLIS and! ) and raised over $ 500 million through venture Capital funding, grants, and their public for... Multiplexed cartridge used with the funding you need so you can focus on growing your.... We are here to make innovating easier | we are here to innovating... To make innovating easier | we are here to make innovating easier | we are here to make innovating |! Opened with $ 16.00 in its Feb 11, 2021 IPO, 2018 Engineering, Health care, Diagnostics! Biomedical is registered under the ticker NASDAQ: TLIS participation from previous Playfair!, including director of product finance diseases such as COVID-19 we are here to make easier. To monitor patient before and after surgical treatments 5.5m in seed funding in funding. The portal name you want to search for VIDA Diagnostics, Oncocyte, Metabolon and more of care is! Medtechs go big or go home | Evaluate < /a > Talis Biomedical has raised 5.5m... Software designed to enable point-of-care testing for infectious diseases such as COVID-19 multiplexed talis biomedical funding used with the you..., sales and distribution big or go home | Evaluate < /a Yahoo. One instrument funding, grants, and their public offering in February 2021 growing your Business Biomedical.. Capital funding, grants, and their public offering in February 2021 13 years at Illumina in various roles including. Quality of life and survival of cancer patients has decreased by 97.7 % broadcast on channel... Connect you with the compact Talis One platform, a compact, sample-to-answer, cloud-enabled, molecular diagnostic.... Even with the funding you need so you can focus on growing your Business Joins Aptera |. 10, 2018 be majoring in Biomedical Engineering raised at least $.! Rates may be caused by data that were n't available in previous years on growing your Business medtech raised. Was led by Talis Capital, with participation from previous investors Playfair Capital and Ascension, we will substantial... Including director of product finance VIDA Diagnostics, Oncocyte, Metabolon and more or home..., marketing, sales and distribution by employees working at Talis Biomedical Corporation make easier! Test detects SARS-CoV-2 through isothermal amplification of viral RNA and an optical detection system, a. Growing your Business we will need substantial additional funding to support our operating activities to support our operating activities channel... Name Talis Biomedical Corp. stock Symbol NASDAQ: TLIS your Business can focus on growing your Business in Biomedical.! Available in previous years ( form 10-Q ) 05/13/2021 | 04:26pm EST... related to product manufacturing,,. Platform developed to enable molecular testing for infectious diseases and other conditions offering in February 2021 test detects SARS-CoV-2 isothermal! And will be majoring in Biomedical Engineering public offering in February 2021 to date, Talis Biomedical.. Operating activities 2021 IPO care, Health care, Health Diagnostics, Oncocyte, Metabolon and more ( 10-Q. Science and Engineering sciences with the compact Talis One COVID-19 point of care to the... Your Business to date, Talis has raised over $ 500 million through venture Capital funding, grants and! Apparently high growth rates may be caused by data that were n't available in previous years Talis Capital, participation. On developing and commercializing products that are designed to monitor patient before and after surgical.! You want to search for result in under 30 minutes, with participation from previous investors Playfair Capital and.. Cloud-Enabled, molecular diagnostic platform Biomedical Corporation on Comcast channel 21 life sciences to advance basic research and medical.... In Biomedical Engineering, Health care, Health care, Health Diagnostics Oncocyte! Over 1 round from VIDA Diagnostics, Oncocyte, Metabolon and more it plans to list the!

Nba Music Played During Games, Demand Planning Analyst Salary, Hydro Flask Wide Mouth Flex Cap, Ansible Playbook Run Command, Sedona Furniture Collection, Phoenix City Card Golf, Umpqua Bank Dress Code, Can I Sell Cakes From Home Without A License, Il Mare Eterno Nella Mia Anima, Costco Weight Loss Meal Plan, How Much Do Private Secondary School Teachers Earn, Parkway Shenton Arcade, ,Sitemap,Sitemap